Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope

Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope

Bibliographic Details
Main Authors:	Rajendra Prasad, Nikhil Gupta, Amitabh Banka
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Indian Journal of Medical Research
Online Access:	http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2017;volume=146;issue=3;spage=301;epage=303;aulast=Prasad

Similar Items

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
by: Rajendra Prasad, et al.
Published: (2017-01-01)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
by: Rajendra Prasad, et al.
Published: (2018-01-01)

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
by: Giovanni Sotgiu, et al.
Published: (2017-03-01)

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
by: Philipp du Cros, et al.
Published: (2021-02-01)

Shorter drug regimen of multidrug-resistant tuberculosis and the ambiguity in the World Health Organization recommendations
by: Rabbanie Tariq Wani, et al.
Published: (2019-01-01)

2025 too short time to eliminate tuberculosis from India
by: Rajendra Prasad, et al.
Published: (2017-01-01)

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen
by: Pauline Lempens, et al.
Published: (2020-11-01)

Initial resistance to companion drugs should not be considered an exclusion criterion for the multidrug-resistant tuberculosis shorter treatment regimen
by: Lempens, P., et al.
Published: (2020)

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020
by: Teona Avaliani, et al.
Published: (2021-01-01)

Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
by: Aleksandr Trubnikov, et al.
Published: (2021-04-01)

Drug-resistant tuberculosis: Progress towards shorter and safer regimens
by: Kavitha Saravu, et al.
Published: (2019-01-01)

Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study.
by: Souleymane Hassane-Harouna, et al.
Published: (2020-01-01)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
by: Emanuele Pontali, et al.
Published: (2019-05-01)

Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes.
by: Tom Decroo, et al.
Published: (2020-01-01)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
by: Jay Achar, et al.
Published: (2015-11-01)

High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam
by: Le T. N. Anh, et al.
Published: (2020-03-01)

Multidrug-resistant tuberculosis treatment with linezolid-containing regimen
by: Maham Farshidpour, et al.
Published: (2013-01-01)

Quantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.
by: Scott K Heysell, et al.
Published: (2015-01-01)

Improving TB management and control through innovative shorter anti-tuberculosis regimens
by: Atwine, Daniel
Published: (2017)

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
by: Leibert E, et al.
Published: (2014-07-01)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
by: Hui Xia, et al.
Published: (2020-01-01)

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
by: Arnaud Trébucq, et al.
Published: (2019-12-01)

Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment.
by: Dylan B Tierney, et al.
Published: (2014-01-01)

Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality.
by: Carole D Mitnick, et al.
Published: (2013-01-01)

Cost-effectiveness of treating multidrug-resistant tuberculosis.
by: Stephen C Resch, et al.
Published: (2006-07-01)

Shorter antibiotic regimens impact the control efforts in high tuberculosis burden regions of Taiwan
by: Yi-Jun Lin, et al.
Published: (2020-08-01)

Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.
by: Mariam O Fofana, et al.
Published: (2014-01-01)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
by: Denise Rossato Silva, et al.

Antimicrobial peptides: new hope in the war against multidrug resistance
by: James Mwangi, et al.
Published: (2019-11-01)

Fluoroquinolones resistance in multidrug-resistant tuberculosis in Pakistan and suitability of guidelines recommended standardized regimen
by: Nafees Ahmad, et al.
Published: (2015-01-01)

Preventing orodental diseases is still better and cheaper than treating them
by: Abdullah R AlShammery
Published: (2017-01-01)

Integrated Care: Better and Cheaper
by: Liliane Rocha
Published: (2019-08-01)

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
by: Jennifer Furin, et al.
Published: (2016-03-01)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
by: Pravin K. Singh, et al.
Published: (2019-09-01)

Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK.
by: Lara J Wolfson, et al.
Published: (2015-01-01)

Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis
by: Hyun Lee, et al.
Published: (2017-12-01)

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
by: Zarir F Udwadia, et al.
Published: (2016-01-01)

Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety
by: Jing-Tao Gao, et al.
Published: (2021-03-01)

Prevention is better and cheaper than cure
by: Ramchandra Dattatraya Lele
Published: (2014-01-01)

Cheaper Adjoints by Reversing Address Computations
by: L. Hascoët, et al.
Published: (2008-01-01)